103 related articles for article (PubMed ID: 10571992)
1. Antigenic surveillance of the influenza virus by mass spectrometry.
Kiselar JG; Downard KM
Biochemistry; 1999 Oct; 38(43):14185-91. PubMed ID: 10571992
[TBL] [Abstract][Full Text] [Related]
2. Antigenic characterisation of H3N2 subtypes of the influenza virus by mass spectrometry.
Morrissey B; Streamer M; Downard KM
J Virol Methods; 2007 Nov; 145(2):106-14. PubMed ID: 17588679
[TBL] [Abstract][Full Text] [Related]
3. Subtyping of the influenza virus by high resolution mass spectrometry.
Schwahn AB; Wong JW; Downard KM
Anal Chem; 2009 May; 81(9):3500-6. PubMed ID: 19402721
[TBL] [Abstract][Full Text] [Related]
4. Antigenicity of a type A influenza virus through comparison of hemagglutination inhibition and mass spectrometry immunoassays.
Schwahn AB; Downard KM
J Immunoassay Immunochem; 2009; 30(3):245-61. PubMed ID: 19591040
[TBL] [Abstract][Full Text] [Related]
5. Kinetics of antigen-antibody interactions employing a MALDI mass spectrometry immunoassay.
Morrissey B; Downard KM
Anal Chem; 2008 Oct; 80(20):7720-6. PubMed ID: 18816071
[TBL] [Abstract][Full Text] [Related]
6. A proteomics approach to survey the antigenicity of the influenza virus by mass spectrometry.
Morrissey B; Downard KM
Proteomics; 2006 Apr; 6(7):2034-41. PubMed ID: 16502471
[TBL] [Abstract][Full Text] [Related]
7. Epitope specificity plays a critical role in regulating antibody-dependent cell-mediated cytotoxicity against influenza A virus.
He W; Tan GS; Mullarkey CE; Lee AJ; Lam MM; Krammer F; Henry C; Wilson PC; Ashkar AA; Palese P; Miller MS
Proc Natl Acad Sci U S A; 2016 Oct; 113(42):11931-11936. PubMed ID: 27698132
[TBL] [Abstract][Full Text] [Related]
8. Rapid and specific influenza virus detection by functionalized magnetic nanoparticles and mass spectrometry.
Chou TC; Hsu W; Wang CH; Chen YJ; Fang JM
J Nanobiotechnology; 2011 Nov; 9():52. PubMed ID: 22088100
[TBL] [Abstract][Full Text] [Related]
9. Epitopes of an influenza viral peptide recognized by antibody at single amino acid resolution.
Schoofs PG; Geysen HM; Jackson DC; Brown LE; Tang XL; White DO
J Immunol; 1988 Jan; 140(2):611-6. PubMed ID: 2447184
[TBL] [Abstract][Full Text] [Related]
10. I-Ad restricted T cell recognition of influenza hemagglutinin. Synthetic peptides identify multiple epitopes corresponding to antibody-binding regions of the HA1 subunit.
Barnett BC; Burt DS; Graham CM; Warren AP; Skehel JJ; Thomas DB
J Immunol; 1989 Oct; 143(8):2663-9. PubMed ID: 2477451
[TBL] [Abstract][Full Text] [Related]
11. Influenza A hemagglutinin C-terminal anchoring peptide: identification and mass spectrometric study.
Kordyukova LV; Ksenofontov AL; Serebryakova MV; Ovchinnikova TV; Fedorova NV; Ivanova VT; Baratova LA
Protein Pept Lett; 2004 Aug; 11(4):385-91. PubMed ID: 15327372
[TBL] [Abstract][Full Text] [Related]
12. Design and optimization of a multiplex anti-influenza peptide immunoassay.
Drummond JE; Shaw EE; Antonello JM; Green T; Page GJ; Motley CO; Wilson KA; Finnefrock AC; Liang X; Casimiro DR
J Immunol Methods; 2008 May; 334(1-2):11-20. PubMed ID: 18329663
[TBL] [Abstract][Full Text] [Related]
13. HA2-specific monoclonal antibodies as tools for differential recognition of influenza A virus antigenic subtypes.
Varecková E; Mucha V; Kostolanský F; Gubareva LV; Klimov A
Virus Res; 2008 Mar; 132(1-2):181-6. PubMed ID: 18037184
[TBL] [Abstract][Full Text] [Related]
14. The Molecular Determinants of Antibody Recognition and Antigenic Drift in the H3 Hemagglutinin of Swine Influenza A Virus.
Abente EJ; Santos J; Lewis NS; Gauger PC; Stratton J; Skepner E; Anderson TK; Rajao DS; Perez DR; Vincent AL
J Virol; 2016 Sep; 90(18):8266-80. PubMed ID: 27384658
[TBL] [Abstract][Full Text] [Related]
15. [Protective antigen of influenza virus].
Nobusawa E
Nihon Rinsho; 1997 Oct; 55(10):2719-24. PubMed ID: 9360397
[TBL] [Abstract][Full Text] [Related]
16. A synthetic peptide of influenza virus hemagglutinin as a model antigen and immunogen.
Jackson DC; Brown LE
Pept Res; 1991; 4(3):114-24. PubMed ID: 1823182
[TBL] [Abstract][Full Text] [Related]
17. Mass spectrometry analysis of the influenza virus.
Downard KM; Morrissey B; Schwahn AB
Mass Spectrom Rev; 2009; 28(1):35-49. PubMed ID: 18785239
[TBL] [Abstract][Full Text] [Related]
18. Amino Acids in Hemagglutinin Antigenic Site B Determine Antigenic and Receptor Binding Differences between A(H3N2)v and Ancestral Seasonal H3N2 Influenza Viruses.
Wang X; Ilyushina NA; Lugovtsev VY; Bovin NV; Couzens LK; Gao J; Donnelly RP; Eichelberger MC; Wan H
J Virol; 2017 Jan; 91(2):. PubMed ID: 27807224
[TBL] [Abstract][Full Text] [Related]
19. Charged amino acid variability related to N-glyco -sylation and epitopes in A/H3N2 influenza: Hem -agglutinin and neuraminidase.
Huang ZZ; Yu L; Huang P; Liang LJ; Guo Q
PLoS One; 2017; 12(7):e0178231. PubMed ID: 28708860
[TBL] [Abstract][Full Text] [Related]
20. Comparative investigation of monoclonal and polyclonal antibodies directed against strain-specific and common antigenic sites on influenza H1N1 virus hemagglutinin.
Drescher J; Verhagen W; Flik J; Stachan R
Intervirology; 1987; 27(4):205-17. PubMed ID: 2447032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
